Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07737496
PHASE1

A Study of HW243040 in Healthy Participants

Sponsor: Hubei Bio-Pharmaceutical Industrial Technological Institute Inc.

View on ClinicalTrials.gov

Summary

This is a randomised, double-blind, placebo-controlled clinical trial intended to evaluate the safety, tolerability and pharmacokinetic profiles of HW243040 following single and multiple administrations in healthy study participants.

Official title: A Phase 1, Randomized, Double-Blind, Single-Center, Dose-Escalation, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HW243040 in Healthy Participants

Key Details

Gender

All

Age Range

18 Years - 55 Years

Study Type

INTERVENTIONAL

Enrollment

98

Start Date

2026-08-10

Completion Date

2027-05-31

Last Updated

2026-07-30

Healthy Volunteers

Yes

Conditions

Interventions

DRUG

HW243040

HW243040 will be administered orally under fasting or fed conditions.

DRUG

Placebo

Placebo will be administered orally under fasting or fed conditions.

Locations (1)

The Third Xiangya Hospital of Central South University

Changsha, Hunan, China